|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
Task Force: Enter the Fixers
Author(s)Kevin Gopal
A new task force will examine European pharma}s competitiveness, innovation, and commitment to public health. The "G10" is not, as it may sound, an enlarged grouping of the world}s leading industrialized countries. It}s actually far more important than that.
Advertisement
Articles in this issue
about 25 years ago
Policy: Task Mastersabout 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearabout 25 years ago
Friends of Complexityabout 25 years ago
Under Federal Fireabout 25 years ago
The Next Y2Kabout 25 years ago
Political ScienceAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5